In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Zebeta, Bisoprolol Fumarate Drug Master File in Korea (Zebeta, Bisoprolol Fumarate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Zebeta, Bisoprolol Fumarate. The MFDS reviews the Zebeta, Bisoprolol Fumarate KDMF as part of the drug registration process and uses the information provided in the Zebeta, Bisoprolol Fumarate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Zebeta, Bisoprolol Fumarate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Zebeta, Bisoprolol Fumarate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Zebeta, Bisoprolol Fumarate suppliers with KDMF on PharmaCompass.